国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Haemophilus influenzae RNA polymerase sigma-E factor (rpoE) CSB-YP332370HTA
CSB-EP332370HTA
CSB-BP332370HTA
CSB-MP332370HTA
CSB-EP332370HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Sigma-E factor negative regulatory protein homolog (rseA), partial CSB-YP332371HTA1
CSB-EP332371HTA1
CSB-BP332371HTA1
CSB-MP332371HTA1
CSB-EP332371HTA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Pantothenate kinase (coaA) CSB-YP332372HTA
CSB-EP332372HTA
CSB-BP332372HTA
CSB-MP332372HTA
CSB-EP332372HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Probable hemoglobin and hemoglobin-haptoglobin-binding protein 1 (HI_0635), partial CSB-YP332373HTA
CSB-EP332373HTA
CSB-BP332373HTA
CSB-MP332373HTA
CSB-EP332373HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae ATP-dependent DNA helicase rep (rep), partial CSB-YP332374HTA
CSB-EP332374HTA
CSB-BP332374HTA
CSB-MP332374HTA
CSB-EP332374HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae tRNA threonylcarbamoyladenosine biosynthesis protein RimN (rimN) CSB-YP332375HTA
CSB-EP332375HTA
CSB-BP332375HTA
CSB-MP332375HTA
CSB-EP332375HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Probable hemoglobin and hemoglobin-haptoglobin-binding protein 2 (HI_0661), partial CSB-YP332376HTA
CSB-EP332376HTA
CSB-BP332376HTA
CSB-MP332376HTA
CSB-EP332376HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Cell division protein ZapB (zapB) CSB-YP332377HTA
CSB-EP332377HTA
CSB-BP332377HTA
CSB-MP332377HTA
CSB-EP332377HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Cytosol non-specific dipeptidase (pepD) CSB-YP332378HTA
CSB-EP332378HTA
CSB-BP332378HTA
CSB-MP332378HTA
CSB-EP332378HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Thiosulfate sulfurtransferase glpE (glpE) CSB-YP332379HTA
CSB-EP332379HTA
CSB-BP332379HTA
CSB-MP332379HTA
CSB-EP332379HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Ketol-acid reductoisomerase (ilvC) CSB-YP332380HTA
CSB-EP332380HTA
CSB-BP332380HTA
CSB-MP332380HTA
CSB-EP332380HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Putative exopolyphosphatase (ppx) CSB-YP332381HTA
CSB-EP332381HTA
CSB-BP332381HTA
CSB-MP332381HTA
CSB-EP332381HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Regulator of ribonuclease activity B (rraB) CSB-YP332382HTA
CSB-EP332382HTA
CSB-BP332382HTA
CSB-MP332382HTA
CSB-EP332382HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Outer membrane antigenic lipoprotein B (lppB) CSB-YP332383HTA
CSB-EP332383HTA
CSB-BP332383HTA
CSB-MP332383HTA
CSB-EP332383HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Probable hemoglobin and hemoglobin-haptoglobin-binding protein 3 (HI_0712), partial CSB-YP332384HTA
CSB-EP332384HTA
CSB-BP332384HTA
CSB-MP332384HTA
CSB-EP332384HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae ATP-dependent Clp protease ATP-binding subunit ClpX (clpX) CSB-YP332385HTA
CSB-EP332385HTA
CSB-BP332385HTA
CSB-MP332385HTA
CSB-EP332385HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Protease HtpX (htpX), partial CSB-YP332386HTA1
CSB-EP332386HTA1
CSB-BP332386HTA1
CSB-MP332386HTA1
CSB-EP332386HTA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae IMPACT family member HI_0722 (HI_0722) CSB-YP332387HTA
CSB-EP332387HTA
CSB-BP332387HTA
CSB-MP332387HTA
CSB-EP332387HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Der GTPase-activating protein YihI (yihI) CSB-YP332388HTA
CSB-EP332388HTA
CSB-BP332388HTA
CSB-MP332388HTA
CSB-EP332388HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae LPS-assembly protein lptD (lptD), partial CSB-YP332389HTA
CSB-EP332389HTA
CSB-BP332389HTA
CSB-MP332389HTA
CSB-EP332389HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>